Page last updated: 2024-08-23

bisantrene and Leukopenia

bisantrene has been researched along with Leukopenia in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19909 (81.82)18.7374
1990's2 (18.18)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aisner, J; Fuks, JZ; Garbino, C; Kasdorf, H; Van Echo, DA1
Cowan, JD; Osborne, CK; Sandbach, J; Von Hoff, DD1
Crain, SM; Forastiere, AA; Garbino, C; Kasdorf, H; Perry, DJ; Tipping, SJ; Van Echo, DA1
Alberts, DS; Mackel, C; Pocelinko, R; Salmon, SE1
Blum, RH; Hoffman, KS; Levin, M; Muggia, FM; Pinto, CA; Speyer, JL; Spiegel, RJ; Wernz, JC1
Aksentijevich, I; Cardarelli, CO; Gottesman, MM; Pastan, I1
Blough, RR; Johnson, CM; Kilton, LJ; Muntean, B; Stiff, PJ; Sweet, D1
Brown, TD; Cowan, JD; Fleming, TR; Shildt, RA1
Constanzi, JJ; Cowan, JD; Neidhart, JA; Osborne, CK; Vaughn, CB; Von Hoff, DD1
Bancillon, A; Boiron, M; Clark, MJ; Ferme, C; Gisselbrecht, C; Guy, H; Marty, M1
Ettinger, DS; Falkson, G; Kaplan, BM; Muggia, FM; Pandya, KJ; Skeel, RT1

Trials

2 trial(s) available for bisantrene and Leukopenia

ArticleYear
Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
    Cancer research, 1982, Volume: 42, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antineoplastic Agents; Cell Survival; Clinical Trials as Topic; Colony-Forming Units Assay; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Multiple Myeloma; Neoplasms; Urinary Bladder Neoplasms

1982
A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).
    Investigational new drugs, 1985, Volume: 3, Issue:2

    Topics: Adult; Aged; Alopecia; Anthracenes; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Female; Heart Failure; Humans; Leukopenia; Menopause; Middle Aged; Mitoxantrone; Nausea; Random Allocation; Receptors, Estrogen; Vomiting

1985

Other Studies

9 other study(ies) available for bisantrene and Leukopenia

ArticleYear
Treatment of advanced non-small cell lung cancer with bisantrene.
    Cancer treatment reports, 1983, Volume: 67, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Leukocyte Count; Leukopenia; Lung Neoplasms; Male; Middle Aged

1983
Bisantrene, an active drug in patients with advanced breast cancer.
    Cancer treatment reports, 1984, Volume: 68, Issue:2

    Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Nausea; Phlebitis

1984
Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
    Cancer treatment reports, 1984, Volume: 68, Issue:4

    Topics: Adult; Aged; Anthracenes; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local

1984
Phase I clinical trial of 9,10-anthracene dicarboxaldehyde (Bisantrene) administered in a five-day schedule.
    Cancer research, 1982, Volume: 42, Issue:1

    Topics: Anthracenes; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged

1982
Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:6

    Topics: 3T3 Cells; Animals; Anthracenes; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; B-Lymphocytes; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Transfer Techniques; Humans; Leukocytes; Leukopenia; Macrophages; Mice; Mice, Inbred C57BL; Retroviridae

1996
Phase II trial of Bisantrene for metastatic melanoma: an Illinois cancer council study.
    Medical and pediatric oncology, 1991, Volume: 19, Issue:2

    Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Illinois; Infusions, Intravenous; Leukopenia; Male; Melanoma; Middle Aged; Phlebitis; Survival Rate

1991
Phase II trial of bisantrene in hepatocellular carcinoma: a Southwest Oncology Group Study.
    Cancer treatment reports, 1987, Volume: 71, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Anthracenes; Carcinoma, Hepatocellular; Diagnosis-Related Groups; Drug Evaluation; Female; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged

1987
Phase I study of bisantrene in acute nonlymphoblastic leukemia.
    Cancer treatment reports, 1985, Volume: 69, Issue:6

    Topics: Acute Kidney Injury; Adult; Anthracenes; Antibiotics, Antineoplastic; Cholestasis; Drug Evaluation; Female; Humans; Leukopenia; Male; Thrombocytopenia

1985
A phase II study of bisantrene in advanced refractory breast cancer. An Eastern Cooperative Oncology Group pilot study.
    American journal of clinical oncology, 1985, Volume: 8, Issue:5

    Topics: Adult; Aged; Anthracenes; Breast Neoplasms; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Pilot Projects

1985